Newborn Hearing Screening in the Otoferlin Gene Therapy Era
The Viewpoint advocates for updates to newborn hearing screening recommendations to include automated auditory brainstem response testing to determine candidacy for otoferlin ( OTOF ) gene therapy.
Authors
- Dana S. Guggenheim (ORCID: https://orcid.org/0000-0002-1316-4253)
- Lawrence R. Lustig (ORCID: https://orcid.org/0000-0001-6718-9838)
- Kathleen C.Y. Sie (ORCID: https://orcid.org/0000-0002-8695-2787)
- Justin S. Golub
Institutions
- Seattle Children's Hospital (US)
- University of Washington (US)
- Columbia University Irving Medical Center (US)
- Columbia University (US)
Publication Details
- Journal
- JAMA Otolaryngology–Head & Neck Surgery
- Published
- 2026-09-17
- DOI
- https://doi.org/10.1001/jamaoto.2026.2695
- Primary Topic
- Hearing, Cochlea, Tinnitus, Genetics
- Type
- article
- Field-Weighted Citation Impact
- 0.00